Back to Top
Go Back
Journal Photo for Journal of Clinical & Experimental Oncology
Peer reviewed only Open Access

Journal of Clinical & Experimental Oncology (JCEOG)

Publisher : SciTechnol
Oncology Medical Sciences Surgery
e-ISSN 2324-9110
Issue Frequency Bi-Monthly
Impact Factor 2.5
Est. Year 2012
Mobile 442037691765
DOI YES
Language English
APC YES
Impact Factor Assignee GOOGLE SCHOLAR
Email editorialoffice@scitechnol.com

Journal Descriptions

Clinical & Experimental Oncology is a hybrid access journal which also permits unlimited Internet Access to complete Journal content. The journal includes all major themes like research papers, review papers, case reports, online letters to the editors & brief comments on previously published articles or any other relevant findings pertaining but not limited to the field of medical oncology, surgery, radiotherapy and pediatric oncology. Journal of Clinical & Experimental Oncology (JCEOG) (ISSN: 2324-9110) aims to establish channels of communication between academic and research scientific experts by making accessible to the health community, policy makers and to improve medical research worldwide. The journal is dedicated to increasing the depth of medicine and medical sciences across disciplines with the coverage of all areas medical oncology, surgery, radiotherapy, pediatric oncology, cancer diagnosis and therapy. Scope of the Journal: We accept articles pertaining but not limited to the following topics in Oncology: Cancer Treatment For treating the cancer, there are various types of treatment existing based on the impact of the cancer and its effect such as chemotherapy, Radio therapy, immune therapy, Oncologic Surgery, hormone therapy.

Journal of Clinical & Experimental Oncology (JCEOG) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Oncology, Medical Sciences, Surgery, Radiotherapy, Pediatric Oncology, Cancer Research, Clinical Medicine, Experimental Therapeutics , Online , Bi-Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2324-9110, Established: 2012, Impact Factor: 2.5
  • Provides Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing